Morrison

Morrison v. Teva Branded Pharmaceutical Products R&D, Inc.

Good Law
United States District Court, Southern District of CaliforniaOctober 18, 20223:22-cv-01074California1,777 words

Opinion

Trial Court Opinion

y 2 3 4 5 6 7 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 MELISSA MORRISON, an individual; Case No.: 22-cv-1074-GPC-MSB KELLIE VALENCIA, an individual; and KARIE KUEHL, an individual, ORDER GRANTING DEFENDANTS’

MOTION TO STAY

Plaintiffs, 13 v. [ECF No. 7]

TEVA BRANDED

PHARMACEUTICAL PRODUCTS

R&D, INC., f/k/a Teva Global Respiratory Research, LLC.; TEVA

PHARMACEUTICALS USA, INC.;

ALZA CORPORATION; JANSSEN

RESEARCH & DEVELOPMENT LLC

19 f/k/a Johnson & Johnson Research & Development, LLC; ORTHO-MCNEIL

PHARMACEUTICAL, LLC; JANSSEN

21 PHARMACEUTICALS, INC. d/k/a Ortho-McNeil- Janssen Pharmaceuticals, Inc. f/k/a Janssen Pharmaceutica Inc.;

JANSSEN ORTHO LLC; JOHNSON &

JOHNSON; DR. C. LOWELL PARSONS, MD, an individual; and

DOES 1-20,

Defendants. 27 1 Before the Court is Defendants’ Motion to Stay all proceedings pending a ruling by the Judicial Panel on Multidistrict Litigation (“JPML”) on transfer to an MDL court. ECF No. 7. Plaintiffs filed an Opposition on September 30, 2022.…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.